ANDAINJECTIONINJECTABLE
Approved
Apr 2009
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
TECHNETIUM TC 99M SESTAMIBI (kit for the preparation of technetium tc99m sestamibi) by R-Pharm US is radiopharmaceutical activity [moa]. First approved in 2009.
Drug data last refreshed 19h ago
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
R-Pharm US
NJ - Princeton
Worked on TECHNETIUM TC 99M SESTAMIBI at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.